ArticleCureus2026
Optimizing Thyroid Nodule Evaluation: AI Integration Into the Thyroid Imaging Reporting and Data System Through AI-Based Ultrasound Image Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Thyroid nodules are among the most common endocrine abnormalities, with ultrasound serving as the first-line tool for risk stratification. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) standardizes evaluation but is limited by interobserver variability and the time required for detailed interpretation. Artificial intelligence (AI) offers the opportunity to address these limitations and to automate diagnostic processes and enhance diagnostic accuracy. Objective To develop and evaluate a vision-language AI model for ACR-TIRADS-based risk stratification of thyroid nodules on ultrasound. Methodology This retrospective study analyzed 1,000 thyroid ultrasound images collected between March 2024 and January 2025, of which 139 met the inclusion criteria. Images were annotated according to ACR-TIRADS features (composition, echogenicity, shape, margins, echogenic foci). A vision-language AI model (LLaVA-Med, Microsoft Research, Redmond, WA) was trained using a two-stage strategy that included domain-specific pretraining and fine-tuning on a curated dataset. Diagnostic performance was assessed as a binary classification: suspicious (TR3-TR5) vs. non-suspicious (TR1-TR2). Results The model achieved an accuracy of 67%, sensitivity of 71%, specificity of 53%, and precision of 84.6%. The F1 score is an average of an AI algorithm's precision and recall, used to evaluate the algorithm's predictive performance. Our model achieved an F1 score of 77%, and its performance favored sensitivity, reducing the likelihood of missed malignant nodules, though specificity remained moderate. Conclusion The vision-language AI model trained on ACR-TIRADS features demonstrated promising performance in thyroid nodule risk stratification. Its higher sensitivity and explainable outputs reflect its potential as a supportive screening tool in clinical practice, particularly in settings with limited radiological expertise. Further refinement and multi-institutional validation are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.